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Kidney failure is relatively common among Canadians of
Asian origin. However, little is known about the health
outcomes after initiation of renal replacement therapy in this
population. Our study evaluates differences in the likelihood
of renal transplantation and graft loss among Asian and
white patients. We studied 21 523 adults of East Asian, Indo
Asian or white ethnicity who had initiated dialysis in Canada
from 1990–2000. Subjects were followed until death, loss to
follow-up or end of study (2004). The proportion of the
eligible subjects who were East Asian, Indo Asian, or white
was 6, 3, and 91%, respectively. Compared to white patients,
East Asian and Indo Asian patients were significantly less
likely to receive a renal transplant after adjusting for
potential confounding factors. This disparity is greater for
transplants from living donors as compared to those from
deceased donors. The adjusted death censored graft loss in
transplant recipients was not significantly different between
ethnic groups. The adjusted risk of death following
transplantation, however, was significantly lower in Indo
Asian than in white patients. Our findings show that in a
Canadian population, patients of East Asian or Indo Asian
origin had lower rates of renal transplantation than white
patients, especially for living donor transplantation. These
findings warrant further study, especially given the good
graft outcomes in these individuals.
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Canada has relatively large and rapidly growing populations
of people whose ancestors were from Indo Asia (also referred
to as the Indian subcontinent) and East Asia (countries such
as China, Japan, and Korea). In Canada, as in other countries,
people of Asian origin are at increased risk for renal diseases,
leading to a rising prevalence of kidney failure among Indo
and East Asian Canadians.1–3
American studies of Asian people with kidney failure have
tended to focus on East Asians, and have suggested that this
population is at reduced risk of graft loss compared with
whites.4 In contrast, British work typically evaluates people of
Indo Asian descent and indicates similar or worse graft
survival compared with whites.5,6 Limited data suggest that
both these populations have less access to transplantation
than whites. Suggested explanation include socioeconomic
factors which may influence access to medical care,7 and
higher prevalence of blood group types which are less
favorable for transplantation, namely blood type B.8 Few
studies examine access to transplantation or transplantation-
related outcomes in Asian patients outside the United States
or Great Britain.
We conducted this study to evaluate the likelihood of renal
transplantation and risk of graft loss among people of East
Asian or Indo Asian origin who recently initiated dialysis in




There were 26 098 incident dialysis patients in the study, of
whom 2179 patients were not white, East Asian, or Indo
Asian in origin and were therefore excluded. An additional
2396 individuals had missing data on race and were also
excluded. Of the remaining 21 523 incident patients, 1243
(6%) were of East Asian and 736 (3%) were of Indo Asian
origin. Of these patients, 5424 (25%) received a transplant
(1350 (25%) from living donors). The median length of
follow-up from time of dialysis initiation until transplant,
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death, or end of study was 2.5 years (1 day to 15 years).
Furthermore, 250 (1%) patients were lost to follow-up and
were censored after a median period of 1.8 years. Demo-
graphic characteristics of study participants appear in Table 1.
East Asian patients were more likely to have glomerulone-
phritis as the cause of kidney failure, and had less
comorbidity such as coronary disease and chronic heart
failure than either Indo Asian or white subjects (Table 1).
Indo Asian patients were younger and more likely to have
diabetic nephropathy than either East Asian or white
patients. Both East Asian and Indo Asian patients were more
likely to live in low income neighborhoods and less likely to
have a rural location of residence.
There were also significant differences in blood group type
by race, among the 14 540 (68%) participants who had
information on this characteristic. The proportion of Indo
Asian participants with type O, A, B, and AB blood group
was 35, 25, 33, and 8%, respectively, as compared with 41, 28,
23, and 8% among East Asian and 45, 41, 11, and 4% among
white participants. As blood groups A and AB are associated
with a higher likelihood of transplantation than groups O
and B, and as group A is much more common than group
AB, these differences are likely to place East and Indo Asian
patients at a relative disadvantage compared with whites.
Transplantation
Adjusted transplantation rates per 100 patient years during
the study period were 4.5 (95% confidence interval (CI)
3.8–5.2), 4.4 (95% CI 3.7–5.2) and 6.3 (95% CI 5.6–7.0) for
East Asian, Indo Asian, and white patients, respectively
(pairwise comparisons vs white patients; both Po0.0001).
Table 1 | Demographics and clinical characteristics
n (%)
East Asian Indo Asian White P-value
N 1243 (6) 736 (3) 19 544 (91)
Age (years)a 65 (48, 73) 58 (46, 67) 64 (50, 73) o0.0001
Male 672 (54) 455 (62) 11 895 (61) o0.0001
Cause of ESRD
Diabetic nephropathy 346 (28) 297 (40) 5342 (27) o0.0001
Glomerulonephritis 325 (26) 131 (18) 3352 (17) o0.0001
Hypertensive/ischemic renal disease 205 (16) 104 (14) 4038 (21) o0.0001
Polycystic kidney disease 29 (2) 28 (4) 1169 (6) o0.0001
Other 338 (27) 176 (24) 5643 (29) 0.007
Comorbidity
Diabetes mellitusb 73 (6) 51 (7) 1322 (7) 0.46
Coronary diseasec 263 (21) 239 (32) 6514 (33) o0.0001
Chronic heart failure 282 (23) 265 (36) 5524 (28) o0.0001
Stroke or TIA 88 (7) 60 (8) 2041 (10) 0.0001
Chronic lung disease 31 (2) 26 (4) 2127 (11) o0.0001
Peripheral vascular disease 89 (7) 93 (13) 3589 (18) o0.0001
Malignancy 64 (5) 19 (3) 1852 (9) o0.0001
Current smoker 54 (4) 39 (5) 2895 (15) o0.0001
Initial peritoneal dialysis modality 523 (42) 321 (44) 5502 (28) o0.0001
Lowest quintile of SES 369 (30) 235 (32) 4407 (23) o0.0001
Year of dialysis initiation
1990–1992 227 (18) 132 (18) 4017 (21) 0.04
1993–1994 209 (17) 122 (17) 3242 (17) 0.98
1995–1996 241 (19) 120 (16) 3638 (19) 0.22
1997–1998 271 (22) 162 (22) 4170 (21) 0.85
1999–2000 295 (24) 200 (27) 4477 (23) 0.02
Rural 25 (2) 8 (1) 4220 (22) o0.0001
Blood group type
O 312 (41) 157 (35) 5948 (45) o0.0001
A 212 (28) 113 (25) 5405 (41) o0.0001
B 178 (23) 150 (33) 1436 (11) o0.0001
AB 58 (8) 35 (8) 536 (4) o0.0001
ESRD, end-stage renal disease; SES, socioeconomic status; TIA, transient ischemic attack.
East Asian=participants from Indonesia, China, Philippines, Vietnam, Laos, Singapore, Japan, and Korea; Indo Asian=participants from India, Pakistan, Bangladesh, Nepal,
Maldives, and Afghanistan.
aMedian (interquartile range) and P-value from Kruskal–Wallis test otherwise n (%) and P-value from w2 test.
bIn participants for whom the primary cause of ESRD was not diabetic nephropathy.
cIncludes angina, prior myocardial infarction or prior coronary revascularization.
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Among patients receiving a transplant, the proportion
originating from a living donor was significantly lower
among East Asian recipients (12%) than either Indo Asian
(20%) or white (26%) recipients (Po0.0001). The adjusted
likelihood of transplantation was substantially lower for both
East Asian and Indo Asian patients than for white patients,
especially for living donor transplantation (Po0.0001,
Table 2).
In the subgroup of patients for whom blood group type
was available, additional adjustment for this characteristic
did not appreciably change the overall likelihood of
transplantation associated with East Asian (hazard ratio
(HR) 0.67 and 0.71 with and without adjustment for blood
group type) or Indo Asian (HR 0.71 and 0.69 with and
without adjustment for blood group type, respectively) race.
However, there was a significant interaction between Indo
Asian race and blood group type on the likelihood of
transplantation (P¼ 0.006). Specifically, among those of AB
blood group type, transplantation was nonsignificantly more
likely in Indo Asians than in white patients (HR 1.35, 95% CI
0.82–2.24). However, Indo Asians were significantly less likely
than white patients to receive transplants in strata defined by
all other blood group types, with HR of 0.60 (95% CI
0.46–0.78), 0.70 (95% CI 0.54–0.92), 0.69 (95% CI 0.51–0.92)
for types O, A, and B, respectively.
There was no evidence that patient age, sex, diabetic
status, socioeconomic status, initial dialytic modality or
informative censoring influenced the association between
race and transplantation. Three additional sensitivity analyses
that reclassified the race of all subjects who were of unknown
race as white, or as East Asian, or as South Asian (in turn,
one at a time) did not affect the findings. Specifically, the rate
of transplantation remained significantly lower among East
or South Asian patients that in white patients for all three
analyses.
Because we did not have information on transplant wait-
list status, it is possible that comorbid disease affected
eligibility and thus rates of transplantation. Therefore, we
performed an additional analysis considering only younger
patients with less comorbidity (age o60 years without
known coronary disease, chronic heart failure, stroke, chronic
lung disease, peripheral vascular disease, known malignancy,
or other serious medical illness that would be expected to
reduce life expectancy). In the remaining 4135 patients, Indo
Asian and East Asian race were again independently
associated with lower rates of renal transplantation (HR
0.66, 95% CI 0.55–0.80 and HR 0.70, 95% CI 0.61–0.79,
respectively).
Graft loss and death after transplantation
Adjusted graft failure rates per 100 patient years during the
study period were 4.5 (95% CI 3.3–6.3), 3.9 (95% CI 2.7–5.8),
and 5.3 (95% CI 4.1–6.8) for East Asian, Indo Asian, and
white patients, respectively. The likelihood of graft loss was
similar in all three racial groups whether death was
considered a cause of graft failure or not (Table 3). There
was no significant interaction between older recipient age,
male sex, or dialytic modality and the risk of graft loss by
race, suggesting that graft survival in Asians and non-Asians
was similar regardless of these characteristics. Although the
risk of death among transplant recipients did not significantly
differ between East Asian and white recipients (HR 0.72, 95%
CI 0.49–1.04), Indo Asian transplant recipients were at
markedly lower risk of post-transplantation death than white
recipients (HR 0.44, 95% CI 0.25–0.79) (Table 3 and
Figure 1).
DISCUSSION
After statistical adjustment, East and Indo Asian dialysis
patients were significantly less likely than white patients to
receive a kidney transplant. The disparity was even more
pronounced when considering transplants obtained from a
living donor, which is important, as this inequity is
potentially amenable to intervention. Although East and
Indo Asian patients were both less likely than white patients
to have relatively favorable blood group types, their like-
lihood of transplantation remained lower than white patients
after adjustment for this characteristic, suggesting that other
factors are responsible for the disparity. We also found that
the risk of death following transplantation was similar or
Table 2 | Transplantation by race
















380 (31) 0.88 (0.79, 0.97) 0.71 (0.63, 0.79) 335 (27) 1.03 (0.92, 1.15) 0.90 (0.80, 1.01) 45 (3.6) 0.42 (0.31, 0.56) 0.27 (0.20, 0.37)
Indo
Asian
203 (28) 0.69 (0.60, 0.80) 0.69 (0.60, 0.80) 163 (22) 0.74 (0.63, 0.87) 0.82 (0.70, 0.97) 40 (5.4) 0.55 (0.40, 0.75) 0.42 (0.31, 0.58)
White 4841 (25) 1.0 1.0 3576 (18) 1.0 1.0 1265 (6.5) 1.0 1.0
CHD, coronary heart disease; CHF, chronic heart failure; CI, confidence interval; DM, diabetes mellitus; ESRD, end-stage renal disease; HR, hazard ratio; HTN, hypertension;
SES, socioeconomic status; TIA, transient ischemic attack.
East Asian=participants from Indonesia, China, Philippines, Vietnam, Laos, Singapore, Japan, and Korea; Indo Asian=participants from India, Pakistan, Bangladesh, Nepal,
Maldives, and Afghanistan.
The median year of transplant (interquartile range) among those receiving transplants was 1999 (1995, 2001) for East Asians, 1998 (1995, 2001) for South Asians, and 1997
(1994, 2000) for white patients.
aAdjusted for age, sex, primary cause of ESRD, year of diagnosis, comorbidities (DM, CHD, HTN, CHF, stroke or TIA, chronic lung disease, serious medical illness, peripheral
vascular disease, malignancy), smoking status, initial dialytic modality, SES, rural status, and geographic region.
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lower in East Asian patients than in white patients, and was
lowest among Indo Asian transplant recipients, in whom the
risk was approximately 50% lower than in white recipients.
This finding is similar to the generally good outcomes
reported among incident East and Indo Asian dialysis
patients, who have lower mortality rates compared with
white patients.9
In contrast to earlier studies which showed slightly worse
graft survival in Indo Asians as compared with white
patients,5 we found that graft outcomes were similar in
patients from all three racial groups. Our findings are similar
to a recent study from the United Kingdom, which found
equivalent graft outcomes in Indo Asian and white patients.6
Our findings are slightly different from much larger
American studies, which showed that graft survival was
better in American people of East Asian descent than in white
patients.4,10 Although our study was substantially smaller, the
point estimates for the risk of graft loss among East Asians
are close to unity, suggesting that the discrepant findings are
not likely to be due to low statistical power. Given the
similarity of our findings to those reported in the United
Kingdom (which also has a universal health-care system), we
speculate that ethnic minorities in Canada may have more
equitable access to transplantation services than those in the
United States. However, as our study did not directly
compare outcomes between patients treated in different
countries, this hypothesis will require confirmation in future
studies.
Future studies seeking to determine how to increase
transplantation rates among Asian people should focus on
three general areas. First, educational programs that target
the families and community members of Asian people with
kidney disease should be considered. Studies from the United
Kingdom indicate that Indo Asian people may be less likely
to donate kidneys because of religious beliefs, although other
cultural factors (such as the reticence of family members to
make a decision about donation on behalf of a deceased
relative) may also play a role.11–13 None of the major Asian
religions forbid organ donation, and a 1995 fatwa (edict)
from the Muslim Law Council specifically states that organ
donation is acceptable.11,14 However, studies have shown that
many UK Muslims are unaware of the fatwa, which (if
confirmed in other populations) would suggest that com-
munity-based initiatives involving religious leaders may be
useful for increasing donation.15,16 The merit of this
approach could be tested in prospective clinical trials,
perhaps using a randomized cluster design. In the meantime,
transplantation programs should consider targeted educa-
tional interventions directed at increasing living and deceased
kidney donation for East and Indo Asian patients, especially
as graft outcomes appeared favorable in these populations.
Second, as not all Asian immigrants to Canada speak
fluent English (especially the elderly), some or all of our
findings may be due to a language barrier. Language has been
inadequately studied as a potential obstacle to transplanta-
tion (and to good quality medical care in general). As this
barrier is potentially remediable with the aid of translators,
future studies should examine this possibility in detail.
Finally, the explanation for the lower rate of transplanta-
tion among Asian patients is probably multifactorial. Therefore,
Table 3 | Graft failure or death by race
















92 (24) 0.90 (0.73, 1.11) 0.85 (0.68, 1.06) 61 (16) 1.01 (0.78, 1.31) 0.93 (0.71, 1.23) 31 (8.2) 0.74 (0.52, 1.06) 0.72 (0.49, 1.04)
Indo
Asian
46 (23) 0.80 (0.60, 1.08) 0.75 (0.55, 1.00) 34 (17) 1.03 (0.73, 1.45) 0.96 (0.67, 1.36) 12 (5.9) 0.50 (0.28, 0.88) 0.44 (0.25, 0.79)
White 1450 (30) 1.0 1.0 821 (17) 1.0 1.0 629 (13) 1.0 1.0
CHD, coronary heart disease; CHF, chronic heart failure; CI, confidence interval; DM, diabetes mellitus; ESRD, end-stage renal disease; HR, hazard ratio; HTN, hypertension; SES,
socioeconomic status; TIA, transient ischemic attack.
East Asian=participants from Indonesia, China, Philippines, Vietnam, Laos, Singapore, Japan, and Korea; Indo Asian=participants from India, Pakistan, Bangladesh, Nepal,
Maldives, and Afghanistan.
aAdjusted for age, sex, primary cause of ESRD, year of diagnosis, comorbidities (DM, CHD, HTN, CHF, stroke or TIA, chronic lung disease, serious medical illness, peripheral





East Asian vs White: HR 0.72, 95% Cl 0.49 – 1.04 P =0.08














Figure 1 | Time to death following kidney transplantation, by
race. Curves have been adjusted for age, sex, primary cause of
end-stage renal disease, year of diagnosis, comorbidities (diabetes
mellitus, coronary heart disease, hypertension, chronic heart failure,
stroke or transient ischemic attack, chronic lung disease, serious
medical illness, peripheral vascular disease, malignancy), smoking
status, initial dialytic modality, socioeconomic status, rural
status, geographic region, type of donor, and time on dialysis
(o1, 1–1.9, X2 years).
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comprehensive studies that examine all phases of the
transplantation workup process would be helpful, as has
been done for other ethnic minorities.17 Such studies should
evaluate patient knowledge and preference for transplanta-
tion, provider attitudes, transplant referral, transplant wait-
listing, and factors which influence time on the waiting list
such as intercurrent illness, comorbidity, and immunological
characteristics.7,11,17–23 As the relative importance of such
factors might differ among recent immigrants as compared to
Canadian-born people of Asian descent, future work should
consider these two groups separately. Findings from these
studies will be increasingly relevant to clinical care, as the
proportion of East and Indo Asian people in the general
Canadian population has nearly doubled over the last decade,
and further increases are expected in the future.24,25
Our study has several limitations. First, Asian patients
might be less interested in receiving a kidney transplant than
those of white race, which might partially account for the
observed disparities. Unfortunately, we did not have data on
patient preference for transplantation. Second, bias could
have resulted from the exclusion of patients with unknown
racial status. However, data are unlikely to have been missing
more frequently among East Asian or Indo Asian patients.
Information, which was missing or incorrect at random,
would bias our results toward the null, suggesting that this
limitation is unlikely to have affected our findings. Similarly,
racial status was provided by dialysis center personnel, rather
than by the subjects themselves, and thus race may have been
incorrectly classified in some cases. In addition, the terms we
used to define ethnicity may encompass groups of hetero-
geneous origin – exemplified by people from Guyana and
Pakistan – who might both be classified as Indo-Asian
although the former would be more likely to also have
African ancestors. Although we cannot exclude this possibi-
lity, it is unlikely that differential misclassification occurred
by race. Again, this suggests that any resulting bias would
reduce statistical power rather than result in spurious
findings. Third, we did not have data on donor characteristics
such as age, sex, or terminal kidney function, or on
information relating to the perioperative period such as cold
ischemic time or delayed graft function. Although most
potentially important recipient characteristics were included
in the data set, immunological data (such as panel reactive
antibody peak or human leukocyte antigen mismatch), and
information on rejection episodes, immunosuppressive
therapy, and compliance with medications were not available.
Finally, our study is limited by the lack of data on transplant
wait-list status, although findings were similar when only
subjects who were likely to be good transplant candidates
were included.
In conclusion, we found that patients of East or Indo
Asian origin receiving dialysis in Canada had lower rates of
renal transplantation than white patients, especially for living
donor transplantation. Programs aimed at increasing living
donation in East and Indo Asian communities may be useful
for reducing these disparities.
MATERIALS AND METHODS
Study population and data sources
This study was approved by the ethics review board at the University
of Alberta and was conducted on a random sample of data from the
Canadian Organ Replacement Registry (CORR).3,26 CORR is a
national registry, which collects patient-specific data annually from
all Canadian dialysis centers. Patient data are collected by health
professionals based on personal knowledge of the patient, chart
review, and in some cases, direct inquiry. Using a previously
described process that ensured the privacy of subjects,27 we received
a randomly selected subject-level data set from CORR, which
included demographic, clinical, treatment, and outcomes data for
approximately 73% of all subjects initiating dialysis in Canada
between 1 January 1990 and 31 December 2000.
In the CORR registry, patient race is categorized as white, black,
Aboriginal, Asian, Indian subcontinent, mideast/Arabian, Pacific
Islander, other, and unknown. People of Asian race (East Asian)
included those from Indonesia, China, Philippines, Vietnam, Laos,
Singapore, Japan, and Korea, whereas people from the Indian
subcontinent (Indo Asian) included those from India, Pakistan,
Bangladesh, Nepal, Maldives, and Afghanistan. Determination of
race is made at the discretion of the health-care professional, as
CORR procedure does not require that patients be asked directly
about racial status. As the focus of this study was on individuals of
Asian origin and as the majority of Canadian dialysis patients are
white, individuals who were neither white nor of Asian origin were
excluded from this analysis.
Analyses
The primary outcome was time to receipt of a deceased or living
donor kidney transplant. Follow-up time was defined by the period
beginning at initiation of dialysis and ending at transplantation,
death, loss to follow-up, or end of study (31 December 2004). In
secondary analyses, we also considered time to graft loss among
transplanted patients from time of transplant. The primary
definition of graft loss included death with function; in additional
analyses, we considered the outcome of death-censored graft loss.
The independent associations between East Asian or Indo Asian
race and time to event outcomes were determined using Cox
proportional hazards models, after adjustment for potential
confounders, including age, sex, race (white, East Asian, and Indo
Asian); cause of end-stage renal disease; year of dialysis initiation;
comorbid conditions (diabetes mellitus, coronary disease, previous/
current hypertension, chronic heart failure, stroke or transient
ischemic attack, chronic lung disease, peripheral vascular disease,
malignancy, other serious medical illness); smoking status; initial
mode of dialysis; low socioeconomic status (lowest quintile of mean
neighborhood income); geographic region of residence (Atlantic
Canada, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British
Columbia); rural location of residence (as defined by Statistics
Canada28); and blood group type (O, A, B, or AB). Models
evaluating outcomes after transplantation also adjusted for donor
source (deceased vs living donor) and time on dialysis before
transplantation (o1, 1–1.9, and X2 years). In order to determine
whether the association between race and outcomes differed in
participants with certain clinical characteristics, we explored two-
way interactions between race and age, sex, socioeconomic status,
and initial dialytic modality on the likelihood of the clinical
outcomes. We determined that the proportional hazard assumption
was satisfied by examining plots of the log-negative-log of the
within-group survivorship probabilities vs log-time.
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Missing data were dealt with by assuming that the characteristic
was absent (10% had missing data on one or more comorbid
conditions) or representing the missing data with an indicator
variable (9% had missing data on race and 32% had missing data on
blood group type). Additionally, participants with unknown races
were reclassified as East Asian, Indo Asian, and white in separate
analyses. Results did not differ when analyses were repeated after
deleting or reclassifying all subjects with missing data, so we have
reported results assuming missing comorbid conditions were absent
and excluding subjects of unknown race. The primary analysis did
not include blood group type, given the large number of subjects for
whom this information was unavailable. However, to evaluate
whether our findings were influenced by racial differences in blood
group type, we performed additional analyses, which evaluated the
independent association between race and the likelihood of
transplantation or graft loss after adjustment for blood group type
and the other variables in the final model.
To deal with other methodological uncertainties, the following
sensitivity analyses were conducted. To determine if the relations
between race and the clinical outcomes were influenced by donor
source, we repeated analyses considering only transplants from
deceased donors by censoring follow-up at the time of living donor
transplantation. Additionally, we repeated analyses considering only
transplants from living donors. Because we did not have informa-
tion on transplant wait-list status, it is possible that comorbidity
affected eligibility and thus rates of transplantation. We addressed
this with an additional analysis considering only non-diabetic
subjects aged o60 years without known coronary disease, chronic
heart failure, stroke, chronic lung disease, peripheral vascular
disease, known malignancy, or other serious medical illness that
might reduce the likelihood of wait-listing for transplantation.
Finally, we assessed the potential for informative censoring (as those
who die early are less likely to have received a kidney transplant) by
assuming that those who died would not have received a transplant
if they had survived until the end of the study (i.e. patients who died
were assigned a date of last follow-up of December 31, 2004).
Rates and survival curves were calculated with adjustment for the
mean age and the most frequent levels of the categorical covariates
in the sample. Statistical analyses were performed using Stata SE 9.0
(College Station, TX, USA) and SAS 9.1 (Cary, NC, USA). Statistical
significance was set at Po0.05.
ACKNOWLEDGMENTS
This study was supported by the Alberta Kidney Disease Network.
Salary support was provided by Alberta Heritage Foundation for
Medical Research (Dr Tonelli, Dr Gourishankar, Dr Hemmelgarn),
Canadian Institutes of Health Research (Dr Tonelli, Dr Manns,
Dr Hemmelgarn), Michael Smith Foundation (Dr Gill), Kidney
Foundation of Canada (Dr Klarenbach).
REFERENCES
1. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for
renal replacement therapy in ethnic minorities in England. J Epidemiol
Community Health 1996; 50: 334–339.
2. Randhawa G. The impending kidney transplant crisis for the Asian
population in the UK. Public Health 1998; 112: 265–268.
3. Canadian Institute for Health Information. 2001 Report. Volume 1: Dialysis
and Renal Transplantation, Canadian Organ Replacement Register,
Ottawa, 2001.
4. Katznelson S, Cecka JM. The great success of Asian kidney transplant
recipients. Transplantation 1997; 64: 1850–1852.
5. Jeffrey RF, Woodrow G, Mahler J et al. Indo-Asian experience of renal
transplantation in Yorkshire: results of a 10-year survey. Transplantation
2002; 73: 1652–1657.
6. Dooldeniya MD, Dupont PJ, He X et al. Renal transplantation in
Indo-Asian patients in the UK. Am J Transplant 2006; 6: 761–769.
7. Norris KC, Agodoa LY. Unraveling the racial disparities associated with
kidney disease. Kidney Int 2005; 68: 914–924.
8. Haji NI, Nelson RE, Jones MN et al. Will transplantation of kidneys from
donors with blood group A2 into recipients with blood group B help
British Indo-Asian patients with renal failure? Transplantation 2004; 77:
630–633.
9. Hemmelgarn BR, Chou S, Wiebe N et al. Differences in use of peritoneal
dialysis and survival among East Asian, Indo Asian, and white ESRD
patients in Canada. Am J Kidney Dis 2006; 48: 964–971.
10. Hariharan S, McBride MA, Bennett LE, Cohen EP. Risk factors for renal
allograft survival from older cadaver donors. Transplantation 1997; 64:
1748–1754.
11. Randhawa G. An exploratory study examining the influence of religion on
attitudes towards organ donation among the Asian population in Luton,
UK. Nephrol Dial Transplant 1998; 13: 1949–1954.
12. Darr A, Randhawa G. Awareness and attitudes towards organ donation
and transplantation among the Asian population. A preliminary survey in
Luton, UK. Transpl Int 1999; 12: 365–371.
13. Randhawa G. The challenge of kidney transplantation among minority
ethnic groups in the UK. EDTNA ERCA J 2004; 30: 182–187.
14. Exley C, Sim J, Reid N et al. Attitudes and beliefs within the Sikh
community regarding organ donation: a pilot study. Soc Sci Med 1996; 43:
23–28.
15. Randhawa G. Promoting organ donation and transplantation among
South Asians in the United Kingdom: the role of social networks in the
South Asian community. Prog Transplant 2005; 15: 286–290.
16. Molzahn AE, Starzomski R, McDonald M, O’Loughlin C. Indo-Canadian
beliefs regarding organ donation. Prog Transplant 2005; 15: 233–239.
17. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients’
preferences on racial differences in access to renal transplantation. N Engl
J Med 1999; 341: 1661–1669.
18. Davis C, Randhawa G. Don’t know enough about it!’: awareness and
attitudes toward organ donation and transplantation among the black
Caribbean and black African population in Lambeth, Southwark, and
Lewisham, United Kingdom. Transplantation 2004; 78: 420–425.
19. Sequist TD, Narva AS, Stiles SK et al. Access to renal transplantation
among American Indians and Hispanics. Am J Kidney Dis 2004; 44:
344–352.
20. Bakewell AB, Higgins RM, Edmunds ME. Does ethnicity influence
perceived quality of life of patients on dialysis and following renal
transplant? Nephrol Dial Transplant 2001; 16: 1395–1401.
21. Epstein AM, Ayanian JZ, Keogh JH et al. Racial disparities in access to
renal transplantation – clinically appropriate or due to underuse or
overuse? N Engl J Med 2000; 343: 1537–1544.
22. Powe NR. To have and have not: health and health care disparities in
chronic kidney disease. Kidney Int 2003; 64: 763.
23. Lunsford SL, Simpson KS, Chavin KD et al. Racial differences in coping
with the need for kidney transplantation and willingness to ask for live
organ donation. Am J Kidney Dis 2006; 47: 324–331.
24. Statistics Canada. Ethnocultural Portrait of Canada. 2001 Census of
Canada.
25. Statistics Canada. Ethnic Origin. 1991 Census of Canada. E-STAT database,
1991.
26. Schaubel DE, Stewart DE, Morrison HI et al. Sex inequality in kidney
transplantation rates. Arch Inter Med 2000; 160: 2349.
27. Tonelli M, Hemmelgarn B, Kim AK et al. Association between residence
location and likelihood of kidney transplantation in Aboriginal patients
treated with dialysis in Canada. Kidney Int 2006; 70: 924–930.
28. du Plessis V, Beshiri R, Bollman RD. Definitions of rural. Rural and Small
Town Canada Analysis Bulletin 2001; 3.
504 Kidney International (2007) 72, 499–504
o r i g i n a l a r t i c l e M Tonelli et al.: Asian Canadians and ESRD outcomes
